Mammosphere Formation in Breast Carcinoma Cell Lines Depends upon Expression of E-cadherin

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Manuel Iglesias, Juan ^a   Beloqui, Izaskun ^a   Garcia Garcia, Francisco ^b   Leis, Olatz ^a   Vazquez Martin, Alejandro ^c,d   Eguiara, Arrate ^a   Cufi, Silvia ^c,d   Pavon, Andres ^a   Menendez, Javier A ^c,d   Dopazo, Joaquin ^b,e   Martin, Angel G ^a  

^a Regulation of Cell Growth Laboratory   (Spain)

^b CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^c CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^d GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^e CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

UVOMORULIN;

ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER STEM CELL; CELL AGGREGATION; CELL ASSAY; CELL POPULATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; E CADHERIN GENE; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SILENCING; HUMAN; HUMAN CELL; MAMMOSPHERE; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CADHERINS; CELL LINE, TUMOR; CELL PROLIFERATION; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MCF-7 CELLS; NEOPLASTIC STEM CELLS; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 84885049446     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077281     Document Type: Article

References (46)

1. Visvader JE, Lindeman GJ, (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8: 755-768. doi:10.1038/nrc2499. PubMed: 18784658.
2. O'Brien CA, Kreso A, Dick JE, (2009) Cancer stem cells in solid tumors: an overview. Semin Radiat Oncol 19: 71-77. doi:10.1016/j.semradonc.2008.11.001. PubMed: 19249644.
3. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF, (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988. doi:10.1073/pnas.0530291100. PubMed: 12629218.
4. Mylona E, Giannopoulou I, Fasomytakis E, Nomikos A, Magkou C, et al. (2008) The clinicopathologic and prognostic significance of CD44+/CD24(-/low) and CD44-/CD24+ tumor cells in invasive breast carcinomas. Hum Pathol 39: 1096-1102. doi:10.1016/j.humpath.2007.12.003. PubMed: 18495204.
5. Honeth G, Bendahl P-O, Ringnér M, Saal LH, Gruvberger-Saal SK, et al. (2008) The CD44+/CD24- phenotype is enriched in basal-like breast tumors. Breast Cancer Res BCR 10: R53. doi:10.1186/bcr2051. PubMed: 18559090.
6. Jordan CT, (2009) Cancer stem cells: controversial or just misunderstood? Cell Stem Cell 4: 203-205. doi:10.1016/j.stem.2009.02.003. PubMed: 19265659.
7. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, et al. (2003) In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17: 1253-1270. doi:10.1101/gad.1061803. PubMed: 12756227.
8. Reynolds BA, Weiss S, (1992) Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science (New York, NY) 255: 1707-1710. doi:10.1126/science.1553558. PubMed: 1553558.
9. Diaz-Guerra E, Lillo Ma, Santamaria S, Garcia-Sanz Ja, (2012) Intrinsic cues and hormones control mouse mammary epithelial tree size. FASEB J, 26: 3844-53. doi:10.1096/fj.11-200782. PubMed: 22683848.
10. Serrano M, (2000) The INK4a/ARF locus in murine tumorigenesis. Carcinogenesis 21: 865-869. doi:10.1093/carcin/21.5.865. PubMed: 10783305.
11. Dey D, Saxena M, Paranjape AN, Krishnan V, Giraddi R, et al. (2009) Phenotypic and functional characterization of human mammary stem/progenitor cells in long term culture. PLOS ONE 4: e5329. doi:10.1371/journal.pone.0005329. PubMed: 19390630.
12. Cicalese A, Bonizzi G, Pasi CE, Faretta M, Ronzoni S, et al. (2009) The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell 138: 1083-1095. doi:10.1016/j.cell.2009.06.048. PubMed: 19766563.
13. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, et al. (2005) Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65: 5506-5511. doi:10.1158/0008-5472.CAN-05-0626. PubMed: 15994920.
14. Grimshaw MJ, Cooper L, Papazisis K, Coleman JA, Bohnenkamp HR, et al. (2008) Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells. Breast Cancer Res BCR 10: R52. doi:10.1186/bcr2106. PubMed: 18541018.
15. Cioce M, Gherardi S, Viglietto G, Strano S, Blandino G, et al. (2010) Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs. Cell Cycle (Georgetown, Tex) 9: 2878-2887. PubMed: 20581442.
16. Mani SA, Guo W, Liao M-J, Eaton EN, Ayyanan A, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715. doi:10.1016/j.cell.2008.03.027. PubMed: 18485877.
17. Borgna S, Armellin M, Gennaro A, Di Gennaro A, Maestro R, et al. (2012) Mesenchymal traits are selected along with stem features in breast cancer cells grown as mammospheres. Cell Cycle (Georgetown, Tex) 11: 4242-4251. doi:10.4161/cc.22543. PubMed: 23095640.
18. Oliveras-Ferraros C, Corominas-Faja B, Cufí S, Vazquez-Martin A, Martin-Castillo B, et al. (2012) Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin). Cell Cycle (Georgetown, Tex) 11: 4020-4032. doi:10.4161/cc.22225. PubMed: 22992620.
19. Leis O, Eguiara A, Lopez-Arribillaga E, Alberdi MJ, Hernandez-Garcia S, et al. (2012) Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene 31: 1354-1365. doi:10.1038/onc.2011.338. PubMed: 21822303.
20. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics (Oxf, England) 19: 185-193. doi:10.1093/bioinformatics/19.2.185.
21. Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3PubMed: 16646809.
22. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B Stat Methodol 57: 289-300.
23. Al-Shahrour F, Arbiza L, Dopazo H, Huerta-Cepas J, Mínguez P, et al. (2007) From genes to functional classes in the study of biological systems. BMC Bioinformatics 8: 114. doi:10.1186/1471-2105-8-114. PubMed: 17407596.
24. Medina I, Carbonell J, Pulido L, Madeira SC, Goetz S, et al. (2010) Babelomics: an integrative platform for the analysis of transcriptomics, proteomics and genomic data with advanced functional profiling. Nucleic Acids Res 38: W210-W213. doi:10.1093/nar/gkq388. PubMed: 20478823.
25. Benjamini Y, Yekutieli D, (2001) The control of the false discovery rate in multiple testing under dependency. Ann Statist 29: 1165-1188. doi:10.1214/aos/1013699998.
26. Götz S, García-Gómez JM, Terol J, Williams TD, Nagaraj SH, et al. (2008) High-throughput functional annotation and data mining with the Blast2GO suite. Nucleic Acids Res 36: 3420-3435. doi:10.1093/nar/gkn176. PubMed: 18445632.
27. Onder TT, Gupta PB, Mani Sa, Yang J, Lander ES, et al. (2008) Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 68: 3645-3654. doi:10.1158/0008-5472.CAN-07-2938. PubMed: 18483246.
28. Coles-Takabe BLK, Brain I, Purpura Ka, Karpowicz P, Zandstra PW, et al. (2008) Don't look: growing clonal versus nonclonal neural stem cell colonies. Stem Cells (Dayton, Ohio) 26: 2938-2944. doi:10.1634/stemcells.2008-0558.
29. Leis O, Eguiara A, Lopez-Arribillaga E, (2011) Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene 31(11):: 1354-1365. PubMed: 21822303.
30. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, et al. (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10: 515-527. doi:10.1016/j.ccr.2006.10.008. PubMed: 17157791.
31. Elstrodt F, Hollestelle A, Nagel JHA, Gorin M, Wasielewski M, et al. (2006) BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. Cancer Res 66: 41-45. doi:10.1158/0008-5472.CAN-05-2853. PubMed: 16397213.
32. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, et al. (2000) Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24: 227-235. doi:10.1038/73432. PubMed: 10700174.
33. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80. doi:10.1186/gb-2004-5-10-r80. PubMed: 15461798.
34. Hiraguri S, Godfrey T, Nakamura H, Graff J, Collins C, et al. (1998) Mechanisms of inactivation of E-cadherin in breast cancer cell lines. Cancer Res 58: 1972-1977. PubMed: 9581841.
35. Fillmore CM, Kuperwasser C, (2008) Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res 10: R25. doi:10.1186/bcr2023. PubMed: 18366788.
36. Lehmann C, Jobs G, Thomas M, Burtscher H, Kubbies M, (2012) Established breast cancer stem cell markers do not correlate with in vivo tumorigenicity of tumor-initiating cells. Int J Oncol 41: 1932-1942. PubMed: 23042145.
37. Sarrio D, Franklin CK, Mackay A, Reis-Filho JS, Isacke CM, (2012) Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties. Stem Cells (Dayton, Ohio) 30: 292-303. doi:10.1002/stem.791. PubMed: 22102611.
38. Sarrio D, Franklin CK, Mackay A, (2012) Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties. Stem Cells 30: 292-303. doi:10.1002/stem.791. PubMed: 22102611.
39. Keller PJ, Lin AF, Arendt LM, Klebba I, Jones AD, et al. (2010) Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines. Breast Cancer Res BCR 12: R87. doi:10.1186/bcr2755. PubMed: 20964822.
40. Ricardo S, Vieira AF, Gerhard R, Leitão D, Pinto R, et al. (2011) Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype. J Clin Pathol 51: 1659-1662. PubMed: 21680574.
41. Shaw FL, Harrison H, Spence K, Ablett MP, Simões BM, et al. (2012) A detailed mammosphere assay protocol for the quantification of breast stem cell activity. J Mammary Gland Biol Neoplasia 17: 111-117. doi:10.1007/s10911-012-9255-3. PubMed: 22665270.
42. Piggott L, Omidvar N, Martí Pérez S, Eberl M, Clarkson RWE, (2011) Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL. Breast Cancer Res BCR 13: R88. doi:10.1186/bcr2945. PubMed: 21914219.
43. Pastrana E, Silva-Vargas V, Doetsch F, (2011) Eyes wide open: a critical review of sphere-formation as an assay for stem cells. Cell Stem Cell 8: 486-498. doi:10.1016/j.stem.2011.04.007. PubMed: 21549325.
44. Ryan PL, Foty Ra, Kohn J, Steinberg MS, (2001) Tissue spreading on implantable substrates is a competitive outcome of cell-cell vs. cell-substratum adhesivity. Proc Natl Acad Sci U S A 98: 4323-4327. doi:10.1073/pnas.071615398. PubMed: 11274361.
45. Duguay D, Foty Ra, Steinberg MS, (2003) Cadherin-mediated cell adhesion and tissue segregation: qualitative and quantitative determinants. Dev Biol 253: 309-323. doi:10.1016/S0012-1606(02)00016-7. PubMed: 12645933.
46. Celià-Terrassa T, Meca-Cortés O, Mateo F, Martinez de Paz A, Rubio N, et al. (2012) Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. J Clin Invest 122: 1849-1868. doi:10.1172/JCI59218. PubMed: 22505459.